Amundi
TWST icon

Amundi’s Twist Bioscience TWST Stock Holding History

Amundi’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17
Closed -$638 – 2144
2025
Q1 		$638 Buy
+17
New +$766 ﹤0.01% 2105
2023
Q4 		– Sell
-111
Closed -$1.89K – 2083
2023
Q3 		$1.89K Sell
111
-3,439
-97% -$75.6K ﹤0.01% 1997
2023
Q2 		$70.5K Hold
3,550
– – ﹤0.01% 1848
2023
Q1 		$47.5K Hold
3,550
– – ﹤0.01% 1890
2022
Q4 		$94.9K Buy
3,550
+830
+31% +$24.1K ﹤0.01% 1617
2022
Q3 		$105K Hold
2,720
– – ﹤0.01% 1551
2022
Q2 		$112K Sell
2,720
-101
-4% -$3.58K ﹤0.01% 1430
2022
Q1 		$136K Sell
2,821
-239
-8% -$13.2K ﹤0.01% 1428
2021
Q4 		$182K Hold
3,060
– – ﹤0.01% 1493
2021
Q3 		$327K Buy
3,060
+1,233
+67% +$141K ﹤0.01% 1394
2021
Q2 		$243K Buy
+1,827
New +$212K ﹤0.01% 1343

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Amundi's TWST Position: Q2 2025 in Review

Amundi sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 17 shares — an estimated $638 sold.

Amundi first reported a position in TWST in Q2 2021 and held it in 11 quarters. The position peaked at $327K in Q3 2021. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Amundi reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 17 Twist Bioscience shares in Q2 2025, an estimated $638.
  • Amundi first reported a position in Twist Bioscience in Q2 2021 and held it in 11 quarters.
  • Amundi's Twist Bioscience position peaked at $327K in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.